GGrantIndex
Sort

50,496 grants matching lung cancer

Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer

$652,794
Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2022 · CA

Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk

$652,725
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2022 · MD

Therapeutic Targeting of NSD2 in Lung Adenocarcinoma

$652,695
Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer

$652,690
David T Wong · University Of California Los Angeles · U01 · FY2019 · CA

Impact of enhancements to smartphone-based continuing care for alcohol dependence

$652,631
James R McKay · University Of Pennsylvania · R01 · FY2015 · AA

Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications

$652,625
Mark David Pagel · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Computing, Optimizing, and Evaluating Quantitative Cancer Imaging Biomarkers

$652,612
Sandy A Napel · Stanford University · U01 · FY2015 · CA

Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology

$652,533
Vadim Backman · Northwestern University · R01 · FY2015 · CA

Gene Expression in Nonspecific Orbital Inflammatory Disease

$652,486
James T Rosenbaum · Oregon Health & Science University · R01 · FY2016 · EY

Biologic Specimen Bank for Early Lung Cancer Markers

$652,406
Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA

Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers

$652,392
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Interaction of anti-angiogenic and cytotoxic therapies in colorectal cancer

$652,384
Peter J O'Dwyer · University Of Pennsylvania · R01 · FY2010 · CA

Engineering the Skin Immune System to Induce Systemic Immune Responses

$652,360
Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AR

PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing

$652,278
David Sidransky · Johns Hopkins University · R01 · FY2017 · CA

Role of METTL3 and the m6A Epitranscriptome in cancer

$652,226
Richard I. Gregory · Boston Children'S Hospital · R01 · FY2020 · CA

Calcitriol for Chemoprevention in Preinvasive Bronchial Epithelial Lesions

$652,222
Roswell Park Cancer Institute Corp · R01 · FY2005 · CA

Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models

$652,207
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway

$652,196
Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2025 · CA

Novel metabolomic contrast probes for human lung cancer characterization

$652,061
Christian T Farrar · Massachusetts General Hospital · R01 · FY2023 · CA

Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis

$652,042
Han Xiao · Rice University · R01 · FY2025 · CA

Development of lisinopril for post-exposure mitigation of late effects from a rad

$651,993
Meetha M Medhora · Medical College Of Wisconsin · U01 · FY2014 · AI

Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers

$651,911
Scarlett L Gomez · University Of California, San Francisco · R01 · FY2022 · MD

Development of therapeutic chemokine-based formulations

$651,880
Bira Arya · National Institute On Aging · ZIA · FY2015 · AG

Incorporating Biomarkers to Improve Lung Cancer Risk Prediction

$651,841
Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2018 · CA

Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations

$651,814
Lisa Carter-Bawa · Hackensack University Medical Center · R01 · FY2024 · CA